IN-VIVO PHOSPHATE REDUCTION: LANTHANUM DIOXYCARBONATE VS LANTHANUM CARBONATE TETRAHYDRATE
Back
Abstract Number
WCN23-0106
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection)
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
IN-VIVO PHOSPHATE REDUCTION: LANTHANUM DIOXYCARBONATE VS LANTHANUM CARBONATE TETRAHYDRATE
Co-authors
Khare, A.(1);Gupta, P.(2);Reddy, G.(3);Gupta, S.(4)*;
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Unicycive Therapeutics- Inc., Scientific Affairs, Los Altos, United States;(2)Unicycive Therapeutics- Inc., Pharmaceutical And Business Operations, Los Altos, United States;(3)Unicycive Therapeutics- Inc., Preclinical Research And Development, Los Altos, United States;(4)Unicycive Therapeutics- Inc., Executive, Los Altos, United States;
E-Poster
https://storage.unitedwebnetwork.com/files/184/fe0119d5286d3f8e897d344a24f00ed4.pdf
Audio File
if any